IGF1 and early-onset autosomal dominant Alzheimer disease: Consequently, IGF-1 has been a therapeutic candidate against many disorders including Alzheimer’s disease, Fragile X syndrome, Rett syndrome, amyotrophic lateral sclerosis (ALS) and Parkinson’s disease [10].